News | Mammography | September 18, 2019

Study finds higher breast cancer detection rate per 1,000 exams in men than in women with mammography; cancers also caught earlier

Screening Mammography Could Benefit Men at High Risk of Breast Cancer

September 18, 2019 — Selective mammography screening can provide potentially lifesaving early detection of breast cancer in men who are at high risk for the disease, according to a landmark study published in the journal Radiology.1

Breast cancer in men is a rare but often deadly disease. The American Cancer Society projects that 2,670 new cases of invasive breast cancer will be diagnosed in men in 2019, and about 500 men will die from it.

There are no formal screening guidelines for men in high-risk groups such as those who have a personal history of the disease, breast-cancer-associated genetic mutations or family members who had breast cancer. As a result, men diagnosed with breast cancer tend to have worse outcomes than women.

“Mammographic screening has helped improve the prognosis for women with breast cancer,” said study lead author Yiming Gao, M.D., from the Department of Radiology at New York University Langone Medical Center in New York City. “But men don’t have any formalized screening guidelines, so they are more likely to be diagnosed at a more advanced stage and often don’t do as well as women.”

There is anecdotal evidence that selective screening with mammography in men with identifiable risk factors is beneficial, but little is known as to how and to what extent breast imaging is used in this population.

In the first study of its kind, Gao and colleagues evaluated breast imaging utilization patterns and screening outcomes in 1,869 men, median age 55, who underwent mammography over a 12-year period.

Mammography helped detect a total of 2,304 breast lesions, 149 of which were biopsied. Of those, 41 (27.5 percent) proved to be malignant. The cancer detection rate of 18 per 1,000 exams in men at high risk of breast cancer was significantly higher than the average detection rate of three to five per 1,000 exams in average-risk women. In addition, the cancers in men detected were at an early stage, before they had spread to the lymph nodes, improving the prognosis for survival.

“These results show that it is possible to detect male breast cancer early, and it appears that mammography is effective in targeted screening of high-risk men,” Gao said. “We’ve shown that male breast cancer doesn’t have to be diagnosed only when symptomatic.”

In men, mammographic screening sensitivity, or the ability to detect cancer, was 100 percent, while specificity, or the ability to distinguish breast cancer from other findings, was 95 percent. This excellent performance is related to men having a relative lack of breast fibroglandular tissue that in women often masks abnormal results, the researchers said.

Personal history of breast cancer was the most significant risk factor associated with breast cancer in men. Ashkenazi Jewish ancestry, genetic mutations and first-degree family history of breast cancer were also significant factors.

Currently, the National Comprehensive Cancer Network (NCCN) does not support screening because of a lack of evidence, even in men with elevated risk. Earlier NCCN guidelines suggested consideration of baseline mammograms on an individual basis, an approach the new study results may support.

Moving forward, the researchers hope to see larger multi-institutional studies that have the statistical power to delineate more nuanced information based on different breast cancer risk factors in men.

“Rethinking our strategy toward male breast cancer diagnosis is necessary,” Gao said. “We hope these results will provide a foundation for further investigations, and potentially help pave the way to standardizing screening for certain high-risk groups of men.”

For more information: www.pubs.rsna.org/journal/radiology

 

Reference

1. Gao Y., Goldberg J.E., Young T.K., et al. Breast Cancer Screening in High-Risk Men: A 12-Year Longitudinal Observational Study of Male Breast Imaging Utilization and Outcomes. Radiology, published online Sept. 17, 2019. https://doi.org/10.1148/radiol.2019190971


Related Content

Feature | Radiology Imaging

View the September/October digital edition of Imaging Technology News (ITN), including links to videos, comparison ...

Time September 29, 2022
arrow
News | Radiation Oncology

September 28, 2022 — Populations in U.S. counties defined as more vulnerable based on social factors including ...

Time September 28, 2022
arrow
News | Point-of-Care Ultrasound (POCUS)

September 27, 2022 — Fujifilm Sonosite, Inc. – the world leader in point-of-care ultrasound (POCUS) solutions – has ...

Time September 27, 2022
arrow
News | Breast Density

September 22, 2022 — DenseBreast-info.org (DB-i) announced that it will host the inaugural #WorldDenseBreastDay on ...

Time September 22, 2022
arrow
Feature | Breast Imaging | By Christine Book

Findings from a clinical trial that used artificial intelligence (AI) in an effort to reduce false positives on breast ...

Time September 21, 2022
arrow
News | Women's Health

September 20, 2022 — Scientists from The Tisch Cancer Institute have uncovered a mechanism by which certain breast ...

Time September 20, 2022
arrow
News | Coronavirus (COVID-19)

September 20, 2022 — Children and adolescents who have either recovered from COVID-19 or have long COVID show persistent ...

Time September 20, 2022
arrow
News | MRI Breast

September 16, 2022 — According to ARRS’ American Journal of Roentgenology (AJR), the contrast-enhanced in-phase Dixon ...

Time September 16, 2022
arrow
News | Digital Radiography (DR)

September 16, 2022 — 20/20 Imaging, a division of Konica Minolta Healthcare Americas, Inc., announces the FDA clearance ...

Time September 16, 2022
arrow
Feature | Artificial Intelligence | By Christine Book

What follows is the second part of our coverage of the “Radiology: Artificial Intelligence Fireside Chat” conducted at ...

Time September 16, 2022
arrow
Subscribe Now